<DOC>
	<DOCNO>NCT02096939</DOCNO>
	<brief_summary>Patients primary aldosteronism , prevalent form secondary hypertension , increase rate cardiovascular event , compare patient essential hypertension , even equal severity hypertension . This might partially attribute association increase aldosterone level insulin resistance . How relation explain pathophysiological point view , insufficiently establish . Recently , microvascular dysfunction propose link insulin resistance hypertension . Loss NO-mediated vasodilation important feature microvascular dysfunction ; addition , impaired insulin-mediated microvascular NO production suggest underlie reduction insulin-stimulated glucose disposal characteristic insulin-resistant state . Increased aldosterone level associate insulin resistance , also endothelial dysfunction . In addition , interfere vascular effect insulin . Therefore , investigator hypothesize patient primary aldosteronism , increase aldosterone level induce microvascular dysfunction reduction NO-availability , contribute development insulin resistance , hypertension , addition sodium-retaining effect aldosterone .</brief_summary>
	<brief_title>Microvascular Function Primary Aldosteronism</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperaldosteronism</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Patients primary aldosteronism Age 1870 year Confirmed diagnosis primary aldosteronism Serum potassium &gt; 3.5 mmol/L without supplementation Patients essential hypertension Age 1870 year Secondary cause hypertension exclude Cardiovascular disease ( stroke , coronary artery disease , peripheral vascular disease , congestive heart failure , cardiac shunt , cardiac surgery , pulmonary hypertension , cardiac arrhythmia , family history cardiac arrhythmia sudden cardiac death ) Diabetes mellitus Unstable severe pulmonary disease Inflammatory diseases Alcohol use &gt; 2 U/day ( woman ) / &gt; 3 U/day ( men ) ( Frequent ) use acetylsalicylic acid , NSAID 's , dipyridamole corticosteroid eGFR &lt; 60 mL/min Impairment hepatic function Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>